BiomX Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BiomX Inc. (NYSE American: PHGE) on February 19, 2026, reporting events occurring on February 19 and February 25, 2026. The filing addresses changes to the Company's Board of Directors under Item 5.02.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Alan Moses resigned from the Board of Directors effective immediately on February 19, 2026, citing personal reasons. He reported no disagreement with the Company regarding operations, policies, or practices.
- Appointments: On February 25, 2026, the Board appointed two new directors to fill vacancies:
- Guy Arieli: Appointed as a Class I Director (term expires 2027). He is a pension and investment advisory specialist with experience managing portfolios for corporate and institutional clients, including El Al Airlines.
- Shaked Ran: Appointed as a Class III Director (term expires 2026). He is an investment advisor and portfolio manager with over 20 years of experience in capital markets and risk assessment.
Outlook, Risks, and Compensation
The Board determined that both Mr. Arieli and Mr. Ran are independent under NYSE American rules. They will receive standard director compensation with annual cash fees prorated for the current year. The Company will enter into indemnification agreements with the new directors on terms consistent with existing agreements for other directors. No unusual items, risks, or forward-looking guidance were disclosed in this filing.
Investor Verification Checklist
- Verify the independence status of the new directors (Arieli and Ran) against NYSE American listing standards.
- Review the Company's Annual Report on Form 10-K (filed February 19, 2026) for the specific terms of the director indemnification agreement referenced as Exhibit 10.3.
- Confirm the total number of board vacancies filled and the current composition of the Board following these appointments.
- Check for any subsequent filings regarding the resignation of Alan Moses to ensure no undisclosed conflicts arose.